EKG CardioComm Solutions, Inc.
CardioComm Solutions, Inc. develops and sells advanced software and hardware products, and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets globally. The company offers consumer health monitoring products, including GEMS mobile ECG, GEMS mobile RPM, HeartCheck CardiBeat Mobile ECG device, GlobalCardio, and HeartCheck SMART monitoring. It also provides healthcare professional monitoring products, such as GEMS Sirona, GEMS WIN, and Trident Pro 40L. CardioComm Solutions, Inc. was incorporated in 1989 and is headquartered in Toronto, Canada.…
Industry Peers
Health Information ServicesKey Statistics
About CardioComm Solutions (CVE: EKG)
›
CardioComm Solutions (CVE: EKG) is listed on the TSX Venture Exchange, where its shares trade in CAD. It belongs to the Health Information Services industry, part of the Healthcare sector.
The shares were at 0.0100 CAD on 18 November 2026, down 50.0% over 52 weeks. Its 52-week range is 0.0050 CAD to 0.0200 CAD: the price is 50.0% below the high and 100.0% above the low.
Its market capitalisation is 987.91K CAD.
CardioComm Solutions reports return on equity of 76.8%, an operating margin of -184.7% and revenue up 25.1% year over year.
Its debt exceeds its cash by 884.16K CAD. Its Piotroski F-score is 1 out of 9, a weak reading of its financial health. The next earnings report is expected on 26 November 2026.